Analyst Ratings for Pulmonx Corp. (LUNG)
LUNG Rating Summary
LUNG Price Target Summary
- Highest: $5.00 (Stifel)
- Lowest: $2.50 (Piper Sandler)
- Average: $3.90
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$3.90 (+156.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
Avg. $ Target:
$3.90 (+156.6%)
* Over Last 12-Mos
Rating Score: 5 / 10
Percentile Rank: 52%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/31/2025 | Piper Sandler | Jason Bednar | Downgrade | Neutral (Overweight) |
2.50 (9.00) |
3.09 (1.52) |
-50.81% | Details |
| 3/10/2025 | D. Boral Capital | Jason Kolbert | New Coverage | Buy (N/A) |
17.00 (N/A) |
7.48 (1.52) |
-79.68% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
